New shot for sciatica pain enters first human safety trial
NCT ID NCT07264270
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 24 times
Summary
This early-stage study tests a single injection of C-1101 into the spine area for adults with long-term sciatica pain that hasn't improved with standard care. The main goal is to check safety and side effects compared to a saltwater placebo. Only 24 people will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCIATICA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Consano Bio Research Site
RECRUITINGBroadmeadow, New South Wales, Australia
-
Consano Bio Research Site
RECRUITINGWahroonga, New South Wales, Australia
-
Consano Bio Research Site
RECRUITINGMelbourne, Victoria, Australia
Conditions
Explore the condition pages connected to this study.